On the public citation graph

Application of the QbD Principles in the Development of the Casopitant Mesylate Manufacturing Process. Process Research Studies for the Definition of the Control Strategy of some Drug Substance-CQAs for Stages 2a, 2b, and 2c

0 signed · 28 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1021/op9002032openalex-snapshot

Synthesis of the NK1 Receptor Antagonist GW597599. Part 3: Development of a Scalable Route to a Key Chirally Pure Arylpiperazine Urea, A Happy End

inferredcites →https://doi.org/10.1021/op900242xopenalex-snapshot

Application of Quality by Design Principles to Support Development of a Control Strategy for the Control of Genotoxic Impurities in the Manufacturing Process of a Drug Substance

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4765835openalex-extracted

Polyfunctionalized Organoselenides: New Synthetic Approach from Seleno-Containing Cyanohydrins and Anti-Melanoma Activity

inferred← citeshttps://doi.org/10.1002/adsc.201700846openalex-snapshot

The Synthesis of Chiral α‐Aryl α‐Hydroxy Carboxylic Acids via RuPHOX‐Ru Catalyzed Asymmetric Hydrogenation

inferred← citeshttps://doi.org/10.1002/chem.202500863openalex-snapshot

Synthesis of α‐Aryl and α‐Heteroaryl 4‐Silyloxy Piperidines via a One‐Pot Negishi Cross‐Coupling Approach

inferred← citeshttps://doi.org/10.1007/978-1-4939-2996-2_8openalex-snapshot

Mathematical Tools for the Quantitative Definition of a Design Space

inferred← citeshttps://doi.org/10.1007/978-981-99-8034-5_14openalex-snapshot

Quality by Design in Relation to Clinical Trials

inferred← citeshttps://doi.org/10.1007/s11696-022-02569-3openalex-snapshot

Ensuring regulatory compliance by quality by design (QbD) approach to optimize the manufacturing process of API: ferric ammonium citrate as an example

inferred← citeshttps://doi.org/10.1007/s12247-013-9165-yopenalex-snapshot

Impact of Quality by Design in Process Development on the Analytical Control Strategy for a Small-Molecule Drug Substance

inferred← citeshttps://doi.org/10.1016/b978-0-12-386537-3.00009-5openalex-snapshot

Optimizing Processes by Minimizing Impurities

inferred← citeshttps://doi.org/10.1016/b978-0-12-386537-3.00016-2openalex-snapshot

Process Validation and Implementation

inferred← citeshttps://doi.org/10.1016/j.aca.2011.10.064openalex-snapshot

A risk-based statistical investigation of the quantification of polymorphic purity of a pharmaceutical candidate by solid-state 19F NMR

inferred← citeshttps://doi.org/10.1016/j.bmcl.2024.129860openalex-snapshot

Polyfunctionalized organoselenides: New synthetic approach from selenium-containing cyanohydrins and anti-melanoma activity

inferred← citeshttps://doi.org/10.1016/j.jpba.2010.08.010openalex-snapshot

Detection, identification and quantification of a new de-fluorinated impurity in casopitant mesylate drug substance during late phase development: An analytical challenge involving a multidisciplinary approach

inferred← citeshttps://doi.org/10.1021/acs.cgd.5c01477openalex-snapshot

Crystal Structure Determination of Inseparable Polymorphic Mixtures by 3D ED/MicroED

inferred← citeshttps://doi.org/10.1021/acs.oprd.2c00230openalex-snapshot

Process Development and Optimization of Linagliptin Aided by the Design of Experiments (DoE)

inferred← citeshttps://doi.org/10.1021/acs.oprd.5b00234openalex-snapshot

Robust Crystallization Process Development for the Metastable δ-form of Pyrazinamide

inferred← citeshttps://doi.org/10.1021/acs.oprd.5b00283openalex-snapshot

Optimization of the Preparation of (R)-3,5-Bis(trifluoromethyl)-α-methyl-N-methylbenzylamine l -(−)-Malic Acid Salt through Classical Resolution

inferred← citeshttps://doi.org/10.1021/acs.oprd.9b00215openalex-snapshot

A Quantitative Assay of Sodium Triacetoxyborohydride

inferred← citeshttps://doi.org/10.1021/ja209700jopenalex-snapshot

Rigid P-Chiral Phosphine Ligands with tert -Butylmethylphosphino Groups for Rhodium-Catalyzed Asymmetric Hydrogenation of Functionalized Alkenes

inferred← citeshttps://doi.org/10.1021/op100121sopenalex-snapshot

Development of a Dynamic Kinetic Resolution for the Isolation of an Intermediate in the Synthesis of Casopitant Mesylate: Application of QbD Principles in the Definition of the Parameter Ranges, Issues in the Scale-Up and Mitigation Strategies

inferred← citeshttps://doi.org/10.1021/op100150bopenalex-snapshot

Development of Drug Substances as Mixture of Polymorphs: Studies to Control Form 3 in Casopitant Mesylate

inferred← citeshttps://doi.org/10.1021/op100209copenalex-snapshot

Application of Quality by Design Principles for the Definition of a Robust Crystallization Process for Casopitant Mesylate

inferred← citeshttps://doi.org/10.1021/op1002825openalex-snapshot

Current Practices of Process Validation for Drug Substances and Intermediates

inferred← citeshttps://doi.org/10.1021/op300319topenalex-snapshot

PAT-Enabled Determination of Design Space for Seeded Cooling Crystallization

inferred← citeshttps://doi.org/10.1021/op500169mopenalex-snapshot

Design of Experiments (DoE) and Process Optimization. A Review of Recent Publications

inferred← citeshttps://doi.org/10.1021/op5002935openalex-snapshot

Applications of Gage Reproducibility & Repeatability (GRR): Understanding and Quantifying the Effect of Variations from Different Sources on a Robust Process Development

inferred← citeshttps://doi.org/10.1021/op500295aopenalex-snapshot

Quality by Design in Action 1: Controlling Critical Quality Attributes of an Active Pharmaceutical Ingredient

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.